Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Link
http://link.springer.com/content/pdf/10.1007/s00415-016-8306-x.pdf
Reference7 articles.
1. Hartung H-P, Aktas O, Boyko AN (2015) Alemtuzumab: a new therapy for active relapsing–remitting multiple sclerosis. Mult Scler J 21(1):22–34
2. Thomas K, Eisele J, Rodriguez-Leal FA et al (2016) Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm 3(3):e228
3. Wing MG, Moreau T, Greenwood J, Smith RM, Hale G et al (1996) Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells. J Clin Invest 98(12):2819–2826
4. Breslin S (2007) Cytokine-release syndrome: overview and nursing implications. Clin J Oncol Nurs 11:37–42
5. Maggi E, Vultaggio A, Matucci A (2011) Acute infusion reactions induced by monoclonal antibody therapy. Expert Rev Clin Immunol 7:55–63
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experience;Multiple Sclerosis and Related Disorders;2023-06
2. Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management;Neurotherapeutics;2022-04
3. Inhaled antibodies: Quality and performance considerations;Human Vaccines & Immunotherapeutics;2021-06-30
4. Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis;Autoimmunity Reviews;2021-06
5. Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 cases;Multiple Sclerosis and Related Disorders;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3